Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06033599 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Motivational Interviewing and Mindfulness-Oriented Recovery Enhancement

StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 11 months later Jun 30, 2027 → Jun 2028
See other at-risk trials from Rutgers, The State University of New Jersey

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion pushed from Jun 30, 2027 to Jun 2028
    • Study completion pushed from Jun 30, 2028 to Aug 2028
    v5
  2. Primary completion date: Jun 30, 2026 to Jun 30, 2027
    • Study completion date: Jun 30, 2027 to Jun 30, 2028
    • Site contacts updated at 2 of 2 sites
    v4
  3. Re-verified, no change to tracked fieldsv3
  4. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 2
    • Eligibility criteria shortened, about 12 words
    v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to 1) examine barriers and facilitators to implementation of MI and MORE for polysubstance use and evaluate strategies for optimizing training, fidelity, and clinic uptake, and 2) evaluate patient outcomes related to the effectiveness of MORE decreasing opioid, tobacco, and other drug use.
Trial Details
NCT Number NCT06033599
Lead Sponsor Rutgers, The State University of New Jersey
Collaborators: University of Utah, National Institute on Drug Abuse (NIDA)
Conditions
(from sponsor)		 Polysubstance Abuse, Opioid Use, Tobacco Use
Related terms Tobacco Use
Enrollment 420 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov